1. Home
  2. FATE vs HWBK Comparison

FATE vs HWBK Comparison

Compare FATE & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • HWBK
  • Stock Information
  • Founded
  • FATE 2007
  • HWBK 1865
  • Country
  • FATE United States
  • HWBK United States
  • Employees
  • FATE N/A
  • HWBK N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • HWBK Major Banks
  • Sector
  • FATE Health Care
  • HWBK Finance
  • Exchange
  • FATE Nasdaq
  • HWBK Nasdaq
  • Market Cap
  • FATE 177.7M
  • HWBK 205.8M
  • IPO Year
  • FATE 2013
  • HWBK N/A
  • Fundamental
  • Price
  • FATE $1.14
  • HWBK $28.88
  • Analyst Decision
  • FATE Hold
  • HWBK
  • Analyst Count
  • FATE 7
  • HWBK 0
  • Target Price
  • FATE $3.83
  • HWBK N/A
  • AVG Volume (30 Days)
  • FATE 1.9M
  • HWBK 55.4K
  • Earning Date
  • FATE 08-12-2025
  • HWBK 07-29-2025
  • Dividend Yield
  • FATE N/A
  • HWBK 2.75%
  • EPS Growth
  • FATE N/A
  • HWBK 816.74
  • EPS
  • FATE N/A
  • HWBK 2.75
  • Revenue
  • FATE $13,335,000.00
  • HWBK $72,980,000.00
  • Revenue This Year
  • FATE N/A
  • HWBK N/A
  • Revenue Next Year
  • FATE N/A
  • HWBK N/A
  • P/E Ratio
  • FATE N/A
  • HWBK $10.61
  • Revenue Growth
  • FATE 105.85
  • HWBK 34.33
  • 52 Week Low
  • FATE $0.66
  • HWBK $20.00
  • 52 Week High
  • FATE $5.92
  • HWBK $35.95
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.69
  • HWBK 55.11
  • Support Level
  • FATE $1.05
  • HWBK $27.07
  • Resistance Level
  • FATE $1.18
  • HWBK $30.23
  • Average True Range (ATR)
  • FATE 0.08
  • HWBK 0.74
  • MACD
  • FATE -0.00
  • HWBK 0.21
  • Stochastic Oscillator
  • FATE 54.76
  • HWBK 73.53

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

Share on Social Networks: